Suppr超能文献

静脉注射对乙酰氨基酚用于肩关节置换术后疼痛管理的有效性:一项基于人群的研究。

Effectiveness of intravenous acetaminophen for postoperative pain management in shoulder arthroplasties: A population-based study.

作者信息

Patterson Diana C, Cagle Paul J, Poeran Jashvant, Zubizarreta Nicole, Mazumdar Madhu, Galatz Leesa M, Anthony Shawn G

机构信息

Department of Orthopaedic Surgery, Mount Sinai Health System, New York, NY, USA.

Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

J Orthop Translat. 2018 Oct 16;18:119-127. doi: 10.1016/j.jot.2018.09.004. eCollection 2019 Jul.

Abstract

BACKGROUND

Intravenous acetaminophen (IV APAP) is an option in multimodal postoperative analgesia. Prior trials focus on hip and knee arthroplasties, whereas large-scale data on utilization and effectiveness in shoulder arthroplasties are lacking.

METHODS

Data on 67,494 (452 hospitals) partial/total shoulder arthroplasties were extracted from the Premier claims database (2011-2016). Patients were categorized by receipt and dosage of IV APAP. Multilevel models measured associations between IV APAP and opioid utilization (in oral morphine equivalents), length/cost of stay and opioid-related complications. Effect estimates (adjusted % change) with 95% confidence intervals (CIs) are reported.

RESULTS

IV APAP was used in 17.7% (n = 11,949) of patients with an increasing utilization trend. Most patients received only one dose on the day of surgery (69.5%; n = 8308). When adjusting for relevant covariates, IV APAP was not associated with meaningful effects on outcomes. Specifically, its use (versus no use) was not associated with decreased (but rather somewhat increased) opioid utilization: + 5.4% (CI 3.6-7.1%; P < 0.05).

CONCLUSION

In this first large-scale study that assesses IV APAP in shoulder arthroplasties, IV APAP use was not associated with decreased opioid utilization or the length/cost of stay. These results do not support routine use of IV APAP in this cohort, especially given its high cost.

THE TRANSLATIONAL POTENTIAL FOR THIS ARTICLE

Multimodal pain control to assist in reducing the opioid pain medications are seen as a route to improved postoperative patient outcomes, better pain control and expedited hospital discharge. Acetaminophen plays a significant role in these protocols in many institutions, but it is not established if this expensive IV formulation is superior to the oral formulation. This study evaluates the use and effectiveness of IV acetaminophen following shoulder arthroplasty at a large number of institutions.

摘要

背景

静脉注射对乙酰氨基酚(IV APAP)是多模式术后镇痛的一种选择。先前的试验主要集中在髋关节和膝关节置换术,而关于肩关节置换术中其使用情况和有效性的大规模数据尚缺乏。

方法

从Premier索赔数据库(2011 - 2016年)中提取了67494例(452家医院)部分/全肩关节置换术的数据。患者按IV APAP的使用情况和剂量进行分类。多水平模型测量了IV APAP与阿片类药物使用(以口服吗啡当量计)、住院时间/费用以及阿片类药物相关并发症之间的关联。报告了效应估计值(调整后的百分比变化)及95%置信区间(CI)。

结果

17.7%(n = 11949)的患者使用了IV APAP,且使用趋势呈上升。大多数患者仅在手术当天接受一剂(69.5%;n = 8308)。在调整相关协变量后,IV APAP对结局无显著影响。具体而言,其使用(与未使用相比)与阿片类药物使用减少(反而有所增加)无关:增加5.4%(CI 3.6 - 7.1%;P < 0.05)。

结论

在这项评估肩关节置换术中IV APAP的首次大规模研究中,IV APAP的使用与阿片类药物使用减少或住院时间/费用无关。这些结果不支持在该队列中常规使用IV APAP,尤其是考虑到其高昂的成本。

本文的转化潜力

多模式疼痛控制有助于减少阿片类止痛药的使用,被视为改善术后患者结局、更好地控制疼痛和加快出院的途径。对乙酰氨基酚在许多机构的这些方案中发挥着重要作用,但这种昂贵的静脉制剂是否优于口服制剂尚未确定。本研究评估了大量机构中肩关节置换术后静脉注射对乙酰氨基酚的使用情况和有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验